Anti-Toxoplasma gondii IgG seroprevalence in the general population in Iran: A systematic review and meta-analysis, 2000–2023
PLOS ONE · 29.08.2024 · 19 (8) · e0307941
DOI: 10.1371/journal.pone.0307941 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 29.08.2024. Verfasst von Faezeh Hamidi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, Department of Laboratory Sciences and Microbiology, Tabriz Medical Sciences, Islamic Azad University, Tabriz, Iran. Hauptthemen laut MEDLINE: Toxoplasma, Immunoglobulin G, Toxoplasmosis, Antibodies, Protozoan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Toxoplasmosis ranks among the most prevalent parasitic diseases globally. It seems that chronic toxoplasmosis is associated with several neuropsychiatric and other harmful effects in infected people, therefore, there is a need to investigate the prevalence of toxoplasmosis across various world regions. In this study, we conducted a meticulous meta-analysis to estimate the seroprevalence of anti- Toxoplasma gondii IgG antibodies within the general population in Iran (GPI). International and national scientific databases for studies published between January 1, 2000, and September 30, 2023, were searched. Observational studies reporting anti- T . gondii IgG seroprevalence in the GPI was selected/included. The data were synthesized using a random-effects model to calculate with a 95% confidence interval (95% CI) the national and regional anti- T . gondii IgG seroprevalence rates in Iran. Additionally, subgroup analyses were conducted to investigate the frequency of exposition to T . gondii in different socio-demographic, climatic, and geographical scenarios. From 18661 identified studies, 327 were included in the present meta-analysis, encompassing 122,882 individuals across the 31 Iranian provinces. The pooled nationwide anti- T . gondii IgG seroprevalence among the GPI was determined to be 32.9% (95% CI: 30.9–35.1%). The highest anti- T . gondii IgG seroprevalence was observed in Mazandaran province (North of Iran) (61%), whereas the lowest was in Semnan province (12.5%).Anti- T . gondii IgG seroprevalence demonstrated a higher occurrence in provinces characterized by moderate temperatures of 16–21°C, high relative humidity, and annual precipitation. Additionally, a higher anti- T . gondii IgG seroprevalence was identified among individuals with a habit of consumption of undercooked meat, raw fruits or vegetables, and untreated water. Moreover, those reporting direct contact with cats, possessing a lower level of education, residing in rural areas, being engaged in farming occupations, or playing the role of housewives exhibited higher anti- T . gondii IgG seroprevalence figures.The anti- T . gondii IgG seroprevalence within GPI closely aligns with the estimated worldwide average exposition rates. This underscores the imperative for public health policymakers to prioritize educational efforts regarding toxoplasmosis transmission pathways and its link to harmful effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medical Sciences, Department of Laboratory Sciences and Microbiology, Tabriz Medical Sciences, Islamic Azad University, Tabriz, Iran.
- Health Research Institute, Infectious Diseases and Tropical Medicine Research Centre, Babol University of Medical Sciences, Babol, Iran.
- Communicable Disease Institute, Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran.
- Department of Parasitology and Mycology, School of Medicine, Mazandaran University of Medical Science, Sari, Iran.
- Veterinary Faculty, Animal Health Department, SALUVET, Complutense University of Madrid, Madrid, Spain.
- Faculty of Medicine, Department of Medical Microbiology, Infectious Diseases Research Center, Gonabad University of Medical Science, Gonabad, Iran.
ORCID-Profile: Rafael Calero-Bernal, Hossein Pazoki
Zitieren
APA
Hamidi, F., Rostami, A., Hosseini, S. A., Calero-Bernal, R., Hajavi, J., Ahmadi, R., & Pazoki, H. (2024). Anti-Toxoplasma gondii IgG seroprevalence in the general population in Iran: A systematic review and meta-analysis, 2000–2023. PLOS ONE, 19(8), e0307941. https://doi.org/10.1371/journal.pone.0307941
Vancouver
Hamidi F, Rostami A, Hosseini SA, Calero-Bernal R, Hajavi J, Ahmadi R, et al. Anti-Toxoplasma gondii IgG seroprevalence in the general population in Iran: A systematic review and meta-analysis, 2000–2023. PLOS ONE. 2024;19(8):e0307941. doi:10.1371/journal.pone.0307941
BibTeX
@article{Hamidi2024,
author = {Hamidi, Faezeh and Rostami, Ali and Hosseini, Seyed Abdollah and Calero-Bernal, Rafael and Hajavi, Jafar and Ahmadi, Reza and Pazoki, Hossein},
title = {Anti-Toxoplasma gondii IgG seroprevalence in the general population in Iran: A systematic review and meta-analysis, 2000–2023},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {8},
pages = {e0307941},
doi = {10.1371/journal.pone.0307941}
}
EUVIMED